Skip to content

Research at St Andrews

Evaluation of the molecular bacterial load assay for detecting viable Mycobacterium tuberculosis in cerebrospinal fluid before and during tuberculous meningitis treatment

Research output: Contribution to journalArticlepeer-review

Abstract

New tools to monitor treatment response and predict outcome from tuberculous meningitis (TBM) are urgently required. We retrospectively evaluated the 16S rRNA-based molecular bacterial load assay (MBLA) to quantify viable Mycobacterium tuberculosis in serial cerebrospinal fluid (CSF) from adults with TBM. 187 CSF samples were collected before and during the first two months of treatment from 99 adults TBM, comprising 56 definite, 43 probable or possible TBM, and 18 non-TBM and preserved at −80 °C prior to MBLA. We compared MBLA against MGIT culture, GeneXpert MTB/RIF (Xpert) and Ziehl-Neelsen (ZN) smear. Before treatment, MBLA was positive in 34/99 (34.3%), significantly lower than MGIT 47/99 (47.5%), Xpert 51/99 (51.5%) and ZN smear 55/99 (55.5%). After one month of treatment, MBLA and MGIT were positive in 3/38 (7.9%) and 4/38 (10.5%), respectively, whereas Xpert and ZN smear remained positive in 19/38 (50.0%) and 18/38 (47.4%). In summary, MBLA was less likely to detect CSF bacteria before the start of treatment compared with MGIT culture, Xpert and ZN smear. MBLA and MGIT positivity fell during treatment because of detecting only viable bacteria, whereas Xpert and ZN smear remained positive for longer because of detecting both live and dead bacteria. Sample storage and processing may have reduced MBLA-detectable viable bacteria; and sampling earlier in treatment may yield more useful results. Prospective studies with CSF sampling after 1–2 weeks are warranted.
Close

Details

Original languageEnglish
Article number102084
Number of pages6
JournalTuberculosis
Volume128
Early online date29 Apr 2021
DOIs
Publication statusPublished - May 2021

    Research areas

  • Tuberculosis meningitis, Cerebrospinal fluid, Mcobacterium tuberculois, Viable bacterial load, 16S rRNA

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Unlocking the health system barriers to maximise the uptake and utilisation of molecular diagnostics in low- and middle- income country setting

    Ntinginya, N. E., Kuchaka, D., Orina, F., Mwebaza, I., Liyoyo, A., Miheso, B., Aturinde, A., Njeleka, F., Kiula, K., Msoka, E. F., Meme, H., Sanga, E., Mwanyonga, S., Olomi, W., Minja, L., Joloba, M., Mmbaga, B. T., Amukoye, E., Gillespie, S. H. & Sabiiti, W., 24 Aug 2021, In: BMJ Global Health. 6, 8, 12 p., e005357.

    Research output: Contribution to journalArticlepeer-review

  2. Qualitative assessment of the impact of socioeconomic and cultural barriers on uptake and utilisation of tuberculosis diagnostic and treatment tools in East Africa: a cross-sectional study

    Msoka, E. F., Orina, F., Sanga, E., Miheso, B., Mwanyonga, S., Meme, H., Kiula, K., Liyoyo, A., Mwebaza, I., Aturinde, A., Joloba, M., Mmbaga, B. T., Amukoye, E., Ntinginya, N. E., Gillespie, S. H. & Sabiiti, W., 12 Jul 2021, In: BMJ Open. 11, 7, 9 p., e050911.

    Research output: Contribution to journalArticlepeer-review

  3. Mycobactericidal effect of different regimens measured by molecular bacterial load assay among people treated for multidrug-resistant tuberculosis in Tanzania

    Mbelele, P. M., Mpolya, E. A., Sauli, E., Mtafya, B., Ntinginya, N. E., Addo, K. K., Kreppel, K., Mfinanga, S., Phillips, P. P. J., Gillespie, S. H., Heysell, S. K., Sabiiti, W. & Mpagama, S. G., 19 Mar 2021, In: Journal of Clinical Microbiology. 59, 4, 12 p., e02927-20.

    Research output: Contribution to journalArticlepeer-review

  4. Tuberculosis bacillary load, an early marker of disease severity and treatment response: the utility of tuberculosis Molecular Bacterial Load Assay

    Sabiiti, W., Azam, K., Farmer, E., Kuchaka, D., Mtafya, B., Bowness, R., Oravcova, K., Honeyborne, I., Evangelopoulos, D., McHugh, T. D., Khosa, C., Rachow, A., Heinrich, N., Kampira, E., Davies, G., Bhatt, N., Ntinginya, E. N., Viegas, S., Jani, I., Kamdolozi, M. & 8 others, Mdolo, A., Khonga, M., Boeree, M. J., Phillips, P. PJ., Sloan, D. J., Hoelscher, M., Kibiki, G. & Gillespie, S. H., Jul 2020, In: Thorax. 75, 7, p. 606-608 3 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Centrifugation and decontamination procedures selectively impair recovery of important populations in Mycobacterium smegmatis

    Kennedy, J. A., Baron, V. O., Hammond, R. J. H., Sloan, D. J. & Gillespie, S. H., 1 Aug 2018, (E-pub ahead of print) In: Tuberculosis.

    Research output: Contribution to journalArticlepeer-review

  2. The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay

    Rachow, A., Saathoff, E., Mtafya, B., Mapamba, D., Mangu, C., Rojas-Ponce, G., Ntinginya, N. E., Boeree, M., Heinrich, N., Gillespie, S. H., Hoelscher, M. & PanACEA Consortium, 4 Apr 2018, (E-pub ahead of print) In: Tuberculosis. In press

    Research output: Contribution to journalArticlepeer-review

  3. Defining dormancy in mycobacterial disease

    Lipworth, S., Hammond, R. J. H., Baron, V. O., Hu, Y., Coates, A. & Gillespie, S. H., Jul 2016, In: Tuberculosis. 99, p. 131-142 12 p.

    Research output: Contribution to journalArticlepeer-review

  4. Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB

    Barr, D. A., Kamdolozi, M., Nishihara, Y., Ndhlovu, V., Khonga, M., Davies, G. R. & Sloan, D. J., May 2016, In: Tuberculosis. 98, p. 110-115 6 p.

    Research output: Contribution to journalArticlepeer-review

ID: 274003802

Top